Share this article Share this article CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ -- Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB). Senda's SAB is composed of leading experts across immunology, microbiology, biochemistry, and neurology, and will collaborate with Senda's leadership to support and advance the new research discipline of Intersystems Biology. This discipline focuses on how molecular connections among botanical, bacterial, and human cells—...